Liver cancer in European children: Incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System Project

被引:43
作者
Stiller, C. A.
Pritchard, J.
Steliarova-Foucher, E.
机构
[1] Univ Oxford, Childhood Canc Res Grp, Dept Paediat, Oxford OX2 6HJ, England
[2] Royal Hosp Sick Children, Dept Paediat Oncol & Haematol, Edinburgh EH9 1LF, Midlothian, Scotland
[3] Int Agcy Res Canc, Descript Epidemiol Grp, F-69372 Lyon, France
关键词
childhood cancer; liver neoplasms; hepatoblastorna; hepatocellular carcinoma; Europe; epidemiology; incidence; survival; registry;
D O I
10.1016/j.ejca.2006.05.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Data on 849 children diagnosed with malignant hepatic tumours (International Classification of Childhood Cancer, Group VII) before the age of 15 years during 1978-1997 in Europe were extracted from the ACCIS database. Age-standardised incidence during 1988-1997 was 1.5 per million overall, 1.2 per million for hepatoblastoma and 0.2 per million for hepatic carcinoma. Over 90% of cases of hepatoblastoma occurred before age S years, whereas hepatic carcinoma had a fairly flat age distribution. Both tumours had an incidence in boys of 1.5-1.6 times that in girls. There were no significant time trends in incidence during 1978-1997. Five-year survival from hepatoblastoma diagnosed during 1988-1997 was 63% overall, and ranged from 52% in Eastern Europe to 84% in the North. Survival from hepatic carcinoma was much lower (37%). Between 1978-1982 and 1993-1997, 5-year survival (95% confidence interval (95% CI)) increased from 28% (95% CI 18-39) to 66% (95% CI 55-74) for hepatoblastoma and from 17% (95% CI 6-33) to 50% (95% CI 26-70) for hepatic carcinoma. These increases reflect the impact of advances in treatment of childhood liver cancer at a population level. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2115 / 2123
页数:9
相关论文
共 30 条
[1]   Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS [J].
Ansell, P ;
Mitchell, CD ;
Roman, E ;
Simpson, J ;
Birch, JM ;
Eden, TOB .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (05) :741-748
[2]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[3]  
Bulterys M, 1999, NIH PUBLICATION, P91
[4]   Educational differences in smoking:: international comparison [J].
Cavelaars, AEJM ;
Kunst, AE ;
Geurts, JJM ;
Crialesi, R ;
Grötvedt, L ;
Helmert, U ;
Lahelma, E ;
Lundberg, O ;
Matheson, J ;
Mielck, A ;
Rasmussen, NK ;
Regidor, E ;
do Rosário-Giraldes, M ;
Spuhler, T ;
Mackenbach, JP .
BRITISH MEDICAL JOURNAL, 2000, 320 (7242) :1102-1107
[5]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[6]   Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology Group [J].
Czauderna, P ;
Mackinlay, G ;
Perilongo, G ;
Brown, J ;
Shafford, E ;
Aronson, D ;
Pritchard, J ;
Chapchap, P ;
Keeling, J ;
Plaschkes, J ;
Otte, JB .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) :2798-2804
[7]   Epidemiology of primary hepatic malignancies in US children [J].
Darbari, A ;
Sabin, KM ;
Shapiro, CN ;
Schwarz, KB .
HEPATOLOGY, 2003, 38 (03) :560-566
[8]   Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry [J].
DeBaun, MR ;
Tucker, MA .
JOURNAL OF PEDIATRICS, 1998, 132 (03) :398-400
[9]  
EVANS AE, 1982, CANCER-AM CANCER SOC, V50, P821, DOI 10.1002/1097-0142(19820901)50:5<821::AID-CNCR2820500502>3.0.CO
[10]  
2-K